24
Participants
Start Date
March 29, 2023
Primary Completion Date
May 4, 2023
Study Completion Date
May 18, 2023
JP-1366 20mg tablet
T : JP-1366 20mg tablet after the meal
JP-1366 20mg tablet
R : JP-1366 20mg tablet under fasting condition
Asan Medical Central, Seoul
Lead Sponsor
Onconic Therapeutics Inc.
INDUSTRY